ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
119.662,38
0,08%
S&P 500
5.431,60
-0,04%
US Dollar vs BRL
5,35049
0,00%
Bitcoin
66.120,95
-0,11%
Brent Oil
82,275
0,00%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. Reino Unido
  5. LSE
  6. Gsk Plc (GSK)

  7. Gsk Plc (GSK) Notícias

GSK

Gsk (GSK)

Gsk Plc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:LSE:GSK
DataHoraFonteTítuloCódigoCompanhia
12/06/202411:30RNS Regulatory NewsGSK PLC Director/PDMR ShareholdingLSE:GSKGsk Plc
11/06/202405:32Alliance NewsAlliance NewsTOP NEWS: GSK takes first steps to appeal Zantac ruling in DelawareLSE:GSKGsk Plc
11/06/202403:00RNS Regulatory NewsGSK PLC Statement: Zantac (ranitidine) litigationLSE:GSKGsk Plc
10/06/202415:00Alliance NewsAlliance NewsTOP NEWS: GSK welcomes dismissal of Zantac case in IllinoisLSE:GSKGsk Plc
10/06/202404:39Alliance NewsAlliance NewsGSK gets FDA approval for Arexvy vax in 50-59 year olds at risk of RSVLSE:GSKGsk Plc
10/06/202403:00RNS Regulatory NewsGSK PLC FDA approves Arexvy for adults 50-59 at riskLSE:GSKGsk Plc
03/06/202411:00RNS Regulatory NewsGSK PLC Total Voting RightsLSE:GSKGsk Plc
03/06/202410:01Alliance NewsAlliance NewsGSK immunotherapy bowel cancer drug works for 100% of patientsLSE:GSKGsk Plc
03/06/202409:03RNS Regulatory NewsGSK PLC Unprecedented results in Jemperli trial continueLSE:GSKGsk Plc
03/06/202405:08Alliance NewsAlliance NewsTOP NEWS: GSK vows to appeal adverse Delaware court ruling on ZantacLSE:GSKGsk Plc
03/06/202403:05RNS Regulatory NewsGSK PLC ASCO positive Blenrep DREAMM-8 trial resultsLSE:GSKGsk Plc
24/05/202404:36Alliance NewsAlliance NewsTOP NEWS: GSK celebrates Illinois jury verdict in Valadez caseLSE:GSKGsk Plc
21/05/202404:49Alliance NewsAlliance NewsGSK's depemokimab asthma treatment meets endpoints in latest trialsLSE:GSKGsk Plc
21/05/202403:00RNS Regulatory NewsGSK PLC Positive phase III asthma results for depemokimabLSE:GSKGsk Plc
20/05/202412:11Alliance NewsAlliance NewsIN BRIEF: GSK executive buys GBP20,026 worth sharesLSE:GSKGsk Plc
17/05/202405:03Alliance NewsAlliance NewsTOP NEWS: GSK sells remaining Haleon stake for GBP1.25 billionLSE:GSKGsk Plc
17/05/202403:00RNS Regulatory NewsGSK PLC GSK completes sale of shares in Haleon plcLSE:GSKGsk Plc
16/05/202413:13Alliance NewsAlliance NewsTOP NEWS: GSK to sell remaining holding in spin-off HaleonLSE:GSKGsk Plc
16/05/202412:42RNS Regulatory NewsGSK PLC GSK announces intention to sell shares in HaleonLSE:GSKGsk Plc
13/05/202411:00RNS Regulatory NewsGSK PLC Block listing Interim ReviewLSE:GSKGsk Plc
08/05/202414:21RNS Regulatory NewsGSK PLC Result of AGMLSE:GSKGsk Plc
08/05/202412:57RNS Regulatory NewsGSK PLC Board Committee ChangeLSE:GSKGsk Plc
01/05/202404:50Alliance NewsAlliance NewsTOP NEWS: GSK expects momentum to continue after strong first quarterLSE:GSKGsk Plc
01/05/202403:00RNS Regulatory NewsGSK PLC 1st Quarter ResultsLSE:GSKGsk Plc
24/04/202405:14Alliance NewsAlliance NewsGSK's Jemperli with chemotherapy accepted for priority review by FDALSE:GSKGsk Plc
24/04/202403:00RNS Regulatory NewsGSK PLC US FDA accepts new indication filing for JemperliLSE:GSKGsk Plc
17/04/202404:46Alliance NewsAlliance NewsTOP NEWS: GSK hails data on Shingles vaccine and gonorrhoea treatmentLSE:GSKGsk Plc
17/04/202403:05RNS Regulatory NewsGSK PLC GSK announces additional EAGLE-1 resultsLSE:GSKGsk Plc
17/04/202403:00RNS Regulatory NewsGSK PLC Results from long-term data relating to ShingrixLSE:GSKGsk Plc
16/04/202410:11RNS Regulatory NewsGSK PLC Amendment - Director/PDMR ShareholdingLSE:GSKGsk Plc
 Apresentando as notícias mais relevantes sobre:LSE:GSK

Seu Histórico Recente

COIN
GUESSGBP
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados